RB1 in other tumor types is highly mutated to produce nonfunctional protein products or to disrupt the E2F binding pocket; however, the aforementioned genomic deletions of RB1 are most prevalent within prostate cancer [39]. This evidence concerns the gene RB1 and prostate carcinoma.